Skip to main content
Procopio Logo
U.S. Tax Reform: What’s Ahead For Biotech Startups
U.S. Tax Reform: What’s Ahead For Biotech Startups

The significant overhaul of the US tax code affects all corporations. The impact on biotech startups extends to company formation, structure of equity compensation, and corporate tax rates.

At the same time, San Diego is coming off a strong performance in 2017 for venture capital raised by startups.  Will the changes in the tax code keep the wind at the back of investors, or lure them to other opportunities?

Join Procopio Of Counsel David Boatwright and Partner Paul Johnson, as they and experts from Moss Adams engage in a wide-ranging discussion on what biotech entrepreneurs need to know about the changes in the tax law and how it will impact their businesses from a legal and accounting perspective. And hear from local investors on how they are thinking about adding to their portfolios in 2018.

11:30AM – 12:00PM: Lunch & Networking
12:00PM – 12:30PM: Procopio &  Moss Adams – Major changes in the new tax code and what it means to your statup
12:30PM – 12:40PM:  Investor insight – How the changes in the tax code might affect decisions to fund
12:40PM – 1:00PM: Q&A;

To register for this event click here

U.S. Tax Reform: What’s Ahead For Biotech Startups

Date & Time

Stay up-to-date with the Procopio newsletter.

Sign Up Now


Patrick Ross, Senior Manager of Marketing & Communications
EmailP: 619.906.5740


Suzie Jayyusi, Events Planner
EmailP: 619.515.3818